AI Science Tracker

Mirai: future breast cancer risk from mammograms

MIT · 28 Jan 2021 · medicine

Discovery

MIT

Mirai: future breast cancer risk from mammograms

Mirai, trained on over 200,000 exams, was evaluated on hospital data from the United States, Sweden, and Taiwan. In a comparison of high-risk groups at Massachusetts General Hospital, it identified nearly twice as many future diagnoses as Tyrer-Cuzick; it does not demonstrate reduced mortality.

Technology: Deep learning on mammograms

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Mirai was validated on held-out test sets from MGH, Karolinska and Chang Gung, and identified nearly twice as many future diagnoses as Tyrer-Cuzick in high-risk groups.
  • Still unknown: It does not use prior imaging and is still being validated in more diverse populations, and it does not show reduced mortality.
  • AI role: Deep learning predicted future breast cancer risk from mammograms.

Evidence sources: https://news.mit.edu/2021/robust-artificial-intelligence-tools-predict-future-cancer-0128 · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A10.1126/scitranslmed.aba4373&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 320 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.